Transcripts Formosa Pharmaceuticals, Inc.

Equities

End-of-day quote Taipei Exchange Other stock markets 23:00:00 10/06/2024 BST			5-day change	1st Jan Change
54.2 ^TWD	-1.09%		+1.69%	+8.51%

05-09	Formosa Pharmaceuticals Announces Licensing Agreement with Tabuk Pharmaceuticals, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery	CI
03-07	Formosa Pharmaceuticals, Inc. Announces FDA Approval for the NDA of A Global Innovative Hormone Nanosuspension Eye Drops	CI

No results for this search